These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1732669)

  • 61. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
    Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
    Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
    Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
    Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
    Vila L; Charrin C; Archimbaud E; Treille-Ritouet D; Fraisse J; Felman P; Fiere D; Germain D
    Blut; 1990 Apr; 60(4):223-7. PubMed ID: 2337681
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.
    Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation. A report on 94 cases. Groupe Français de Cytogénétique Hématologique (GFCH).
    Hematol Cell Ther; 1996 Apr; 38(2):177-81. PubMed ID: 8931999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
    Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A
    Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS.
    Ganguly BB; Banerjee D; Agarwal MB
    Blood Cells Mol Dis; 2018 Mar; 69():90-100. PubMed ID: 29079134
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Age- and gender-related heterogeneity of cancer chromosome aberrations.
    Mertens F; Johansson B; Mitelman F
    Cancer Genet Cytogenet; 1993 Oct; 70(1):6-11. PubMed ID: 8221614
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
    Sozzi G; Miozzo M; Orazi A; Calderone C; Castellano M; Viviani S; Santoro A; Pierotti MA; Della Porta G
    Br J Cancer; 1990 Mar; 61(3):425-8. PubMed ID: 2328210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of single chromosome abnormalities in preleukemic states.
    Nowell PC; Besa EC
    Cancer Genet Cytogenet; 1989 Oct; 42(1):1-7. PubMed ID: 2790739
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Chromosome abnormalities in myelodysplastic syndrome].
    Fujita K; Mori H; Niikura H; Terada H; Shinohara T
    Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chromosomal abnormalities in myelodysplastic syndromes and acute myeloid leukemia.
    Machnicki JL; Bloomfield CD
    Clin Lab Med; 1990 Dec; 10(4):755-67. PubMed ID: 2272173
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Leukemic transformation in patients with 5Q- and additional abnormalities.
    Larripa I; Acevedo S; Palau Nagore MV; Bengiò R; Mondini N; Slavutsky I
    Haematologica; 1991; 76(5):363-7. PubMed ID: 1806438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.